GROSSBRITANNIEN

EQS-News: Linde Announces First Quarter 2024 Earnings and Conference Call Schedule

Retrieved on: 
Wednesday, April 10, 2024

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • Woking, UK, April 5, 2024 – Linde (Nasdaq: LIN) will release its first quarter 2024 financial results by 06:00 EDT/midday CEST on Thursday, May 2, 2024.
  • The Company will host and webcast its conference call at 09:00 EDT/15:00 CEST, which will be available to the public and the media in listen-only mode.

RM plc: Director/PDMR Performance Share Plan Award

Retrieved on: 
Wednesday, April 10, 2024

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Key Points: 
  • Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
    Description of the financial instrument, type of instrument
    Grant of an award of nil-cost options over RM plc ordinary shares under the rules of the RM plc Performance Share Plan 2019.

Edison issues update on The Biotech Growth Trust (BIOG): Onwards and upwards for performance recovery

Retrieved on: 
Wednesday, April 10, 2024

The sector was negatively affected by sharply rising interest rates rather than a deterioration in industry fundamentals; indeed, the managers continue to refer to a ‘golden era’ of innovation within the biotech sector.

Key Points: 
  • The sector was negatively affected by sharply rising interest rates rather than a deterioration in industry fundamentals; indeed, the managers continue to refer to a ‘golden era’ of innovation within the biotech sector.
  • BIOG’s relative performance has been through a difficult period given its high weighting in emerging (smaller-cap) biotech stocks, which performed significantly worse than the shares of large-cap biotech businesses during the sector sell-off.
  • BIOG’s managers are very excited about the trust’s prospects and encouraged that investors are once again rewarding biotech companies that deliver positive outcomes.
  • In keeping with many other investment companies, the trust’s discount is wider than its historical averages.

Funding Circle Plc: POS-Transaction in Own Shares

Retrieved on: 
Wednesday, April 10, 2024

Funding Circle Holdings plc (the "Company") announces that it has purchased for cancellation the following number of its ordinary shares of £0.001 each on the London Stock Exchange from Numis Securities Limited (“Deutsche Numis”) as part of its buy-back announced on 7 March 2024:

Key Points: 
  • Funding Circle Holdings plc (the "Company") announces that it has purchased for cancellation the following number of its ordinary shares of £0.001 each on the London Stock Exchange from Numis Securities Limited (“Deutsche Numis”) as part of its buy-back announced on 7 March 2024:
    Number of ordinary shares purchased:
    Highest price paid per share:
    Lowest price paid per share:
    Volume weighted average price paid per share:
    The Company intends to cancel all of the purchased ordinary shares.
  • Following the cancellation of the repurchased shares, the Company's issued share capital will consist of 359,743,191 ordinary shares with voting rights.
  • There are no ordinary shares held in Treasury.
  • The above figure (359,743,191) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Aquis Stock Exchange: withdrawal from trading

Retrieved on: 
Wednesday, April 10, 2024

The issuer is solely responsible for the content of this announcement.

Key Points: 

The issuer is solely responsible for the content of this announcement.
The following securities will be withdrawn from trading in the Aquis Stock Exchange Growth Market with effect from market open today, 18 March 2024:

Molten Ventures Plc: HOL-Holding(s) in Company

Retrieved on: 
Wednesday, April 10, 2024

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Key Points: 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:
5. Date on which the threshold was crossed or reachedvi:
% of voting rights attached to shares (total of 8. A)

Custodian Property Income REIT plc: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

Retrieved on: 
Wednesday, April 10, 2024

Custodian Property Income REIT plc: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

Key Points: 
  • Custodian Property Income REIT plc: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
  • Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
  • Custodian Property Income REIT (LSE: CREI), which seeks to deliver a strong income return by investing in a diversified portfolio of smaller regional properties across the UK, announces that as required by Article 19.3 of Regulation (EU) No.
  • 596/2014 on market abuse (the "Market Abuse Regulations"), the Company was notified on 28 March 2024 of the following transaction between Ian Mattioli, a Non-Executive Director of the Company, and Laura Mattioli, Ian’s daughter, relating to a transfer of ordinary shares from Ian to Laura.

Hardman & Co Research on Arbuthnot Banking Group (ARBB): 2023 - delivering strategy with strong profit growth

Retrieved on: 
Wednesday, April 10, 2024

The saying goes, the proof of the pudding is in the eating.

Key Points: 
  • The saying goes, the proof of the pudding is in the eating.
  • ABG’s 2023 results proved that the strategic positioning of the group, as a relationship bank, has created enormous value.
  • Customer deposits grew 21% to £3.8bn, loans by 6% to £2.3bn and FUM by 29% to £1.71bn.
  • Please click on the link below for the full report:
    If you are interested in meeting the company, you can register your interest by clicking on the above link

Funding Circle Plc: POS-Transaction in Own Shares

Retrieved on: 
Wednesday, April 10, 2024

Funding Circle Holdings plc (the "Company") announces that it has purchased for cancellation the following number of its ordinary shares of £0.001 each on the London Stock Exchange from Numis Securities Limited (“Deutsche Numis”) as part of its buy-back announced on 7 March 2024:

Key Points: 
  • Funding Circle Holdings plc (the "Company") announces that it has purchased for cancellation the following number of its ordinary shares of £0.001 each on the London Stock Exchange from Numis Securities Limited (“Deutsche Numis”) as part of its buy-back announced on 7 March 2024:
    Number of ordinary shares purchased:
    Highest price paid per share:
    Lowest price paid per share:
    Volume weighted average price paid per share:
    The Company intends to cancel all of the purchased ordinary shares.
  • Following the cancellation of the repurchased shares, the Company's issued share capital will consist of 357,863,622 ordinary shares with voting rights.
  • There are no ordinary shares held in Treasury.
  • The above figure (357,863,622) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Holding(s) in Company

Retrieved on: 
Wednesday, April 10, 2024

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

Key Points: 

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above